Close
Back to AWH Stock Lookup

Aspira Women’s Health (AWH) – FDA

May 11, 2023 08:02 AM Aspira Women’s Health (AWH) Signs an Exclusive Licensing Agreement with Dana Farber Cancer Institute for the Development of microRNA-based Ovarian Cancer Test

Back to AWH Stock Lookup